Peptides, BPC-157, and the Mainlining of Pseudoscientific Nonsense 30 years of rat-research and an avalanche of un-earned hype is coming to your clinic Critical Commentary takes a deep dive into one argument on a systemic problem in autoimmune drug development - trial design, regulatory strategy, industry incentives, or the gap between evidence and practice
GLOW blend (GHK-Cu, BPC-157, TB-500): adds the copper peptide GHK-Cu to the BPC-157/TB-500 pairing, extending the research focus to dermal and connective-tissue models
While these effects are generally manageable, they represent more pronounced GI side effects than observed with AOD-9604
Contraindications Given the limited safety data, conservative contraindications would include pregnancy or plans to become pregnant, breastfeeding, age under 18, severe liver or kidney disease, and any condition requiring medications with unknown interaction potential
Biophysical characterization of the unstructured cytoplasmic domain of the human neuronal adhesion protein neuroligin 3
When to choose GHK-Cu GHK-Cu is the better choice for broader regenerative goals
